BusinessCann
BusinessCann · page 20
- Pharmaceutical
Oxford Cannabinoid Technologies Holdings New Partnerships Targeting Trigeminal Neuralgia
OXFORD Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (OCT), a pharmaceutical company developing prescription cannabinoid medicines for approval by key medicines regulatory agencies worldwide and targeting the US$ multi-billion pain market, announces the signing of new partnerships to target trigeminal neuralgia (TN) – an increasingly prevalent chronic pain condition.
- Press releases
Kanabo Partners With Medocann Group To Develop And Distribute Unique Cannabis Strains And Products For UK And Germany
Kanabo, one of Europe’s fastest-growing medical cannabis R&D companies that focuses on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, has signed a partnership agreement with the Medocann Pharma Ltd to develop new products that will target specific medical conditions.
- Press releases
Cantourage Partners With FarmaGrowers To Bring The First South African Medical Cannabis To Germany
EUROPEAN medical cannabis leaders Cantourage and South Africa-based farming enterprise FarmaGrowers have confirmed an agreement to supply South African medical cannabis dried flower products to German pharmacies.
- Press releases
HempFlax Invests €3m In Headquarters Creating The World’s Most Advanced Hemp Processing Facility
HEMPFLAX, Europe’s largest independent hemp grower and processor, is delighted to announce plans to invest €3.0m at its headquarters in Oude Pekela, Holland.
- CBD Market
Yooma Wellness Acquires Japanese Wellness Business For $12m
YOOMA Wellness Inc. (“Yooma“) (CSE: YOOM, AQSE: YOOM), a vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, has announced today that it has completed the acquisition of Tokyo-based Vertex Co., Ltd. (“Vertex”).
- CBD Market
New CIC Standards Group Looks To Tackle the ‘Uncertainty, Misconceptions, And Taboos’ Of A Century Of Prohibition
IN July this year Elisabetta Faenza was appointed chair of the recently-formed UK Cannabis Industry Council’s (CIC) Standards Group, whose 39 members drawn from CBD, hemp and medicinal cannabis companies, the legal profession and researchers, have been tasked with creating a level playing field for the country’s legal hemp and cannabis industry based on clear…
- Press releases
Avida Global Acquires Canna Creations And Green Stem CBD To Become A Fully Vertically-Integrated Seed-To-Sale Business
AVIDA Global has announced the acquisition of Canna Creations, a full-service manufacturing and CBD potency testing business, and Green Stem CBD, Canna Creations’ own CBD brand.
- CBD Market
Yooma Wellness Completes Acquisition of Big Swig, Inc
YOOMA Wellness Inc. (“Yooma”) (CSE: YOOM, AQSE: YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands, today announced that it has completed the acquisition of Big Swig, Inc. (“Big Swig”), a US-based seller of sparkling water beverages.
- CBD Market
eCargo And Mellow UK Announce Asia Distribution Partnership
ECargo Holdings Limited (ASX:ECG) (“eCargo”) today announced its Asia exclusive partnership with UK-based Wellness and CBD marketplace Mellow UK (stylised as ‘mellow’) to distribute and market their brand partners throughout Asia.
- Opinion
Why Precision-Fermented Cannabinoids Should Be The Chosen Path For The European Cannabis Industry
Precision-fermented cannabinoids are likely to disrupt Europe’s emerging medicinal and recreational cannabis-farming industry over the next few years – and that’s a very good thing, says Jim Plamondon.
- CBD Market
Reakiro – Europe’s Leading CBD And Hemp Brand – Delivers The Complete B2B & B2C Package
IN a time when CBD products are becoming unavoidable in the health, wellness and fitness industries, it is more important than ever to be able to trace the products back to the source and establish who exactly are the trusted manufacturers in this business.
- Pharmaceutical
Oxford Cannabinoid Technologies Holdings Sign Exclusive Worldwide License Agreement With Canopy Growth
Oxford Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (“OCT”) (together, the “Group”), a company developing licensed prescription cannabinoid medicines for approval by regulatory agencies worldwide and targeting the U$ multi-billion pain market, is pleased to announce that on 21 September 2021 OCT signed an exclusive licensing agreement with Canopy…
